Search Results - "Bardossy, L"

Refine Results
  1. 1

    o-Raffinose cross-linked hemoglobin improves the hemostatic defect associated with anemia and thrombocytopenia in rabbits by Lee, David H., Bardossy, Leslie, Peterson, Nichole, Blajchman, Morris A.

    Published in Blood (15-11-2000)
    “…Several different preparations of cross-linked hemoglobin (CLHb) are being evaluated for their efficacy and safety as red cell substitutes in a variety of…”
    Get full text
    Journal Article
  2. 2

    The contribution of the haematocrit to thrombocytopenic bleeding in experimental animals by Blajchman, M A, Bordin, J O, Bardossy, L, Heddle, N M

    Published in British journal of haematology (01-02-1994)
    “…Clinical studies in anaemic uraemic patients have shown that increasing the haematocrit with either red blood cell (RBC) transfusions or erythropoietin…”
    Get more information
    Journal Article
  3. 3

    Psoralen-mediated photodecontamination of platelet concentrates: inactivation of cell-free and cell-associated forms of human immunodeficiency virus and assessment of platelet function in vivo by Margolis-Nunno, H., Bardossy, L., Robinson, R., Ben-Hur, E., Horowitz, B., Blajchman, M. A.

    Published in Transfusion (Philadelphia, Pa.) (01-09-1997)
    “…BACKGROUND: Treatment of platelet concentrates (PCs) with psoralens and broad‐band ultraviolet A (UVA) radiation is being examined for the elimination of…”
    Get full text
    Journal Article
  4. 4

    Prevention of transfusion-associated Chagas' disease: efficacy of white cell-reduction filters in removing Trypanosoma cruzi from infected blood by Moraes-Souza, H, Bordin, J O, Bardossy, L, MacPherson, D W, Blajchman, M A

    Published in Transfusion (Philadelphia, Pa.) (01-09-1995)
    “…Transfusion-associated Chagas' disease (TA-CD) is a worldwide problem. Measures adopted to prevent TA-CD include the clinical and serologic screening of blood…”
    Get more information
    Journal Article
  5. 5

    Experimental animal model of refractoriness to donor platelets: the effect of plasma removal and the extent of white cell reduction on allogeneic alloimmunization by Bordin, J O, Bardossy, L, Blajchman, M A

    Published in Transfusion (Philadelphia, Pa.) (01-10-1993)
    “…Platelet transfusion effectiveness may be limited in multiply transfused patients by the development of the refractory state. White cell (WBC)-reduction…”
    Get more information
    Journal Article
  6. 6

    Platelet concentrates stored for 5 days in a reduced volume of plasma maintain hemostatic function and viability by Ali, A M, Warkentin, T E, Bardossy, L, Goldsmith, C H, Blajchman, M A

    Published in Transfusion (Philadelphia, Pa.) (01-01-1994)
    “…Platelet concentrates prepared from whole blood are generally suspended in a standard volume of 50 to 60 mL of plasma and can be stored thus at 20 to 24…”
    Get more information
    Journal Article
  7. 7

    Rapid in vivo induction of leukocyte tissue factor mRNA and protein synthesis following low dose endotoxin administration to rabbits by Brutzki, T C, Kulczycky, M J, Bardossy, L, Clarke, B J, Blajchman, M A

    “…Disseminated intravascular coagulation in humans is frequently associated with Gram-negative bacterial sepsis. Therefore, to examine the role and time frame of…”
    Get more information
    Journal Article
  8. 8

    Treatment of T. cruzi infected human platelet concentrates with aminomethyltrimethyl psoralen (AMT) and ultraviolet A (UV-A) light: preliminary results by Moraes-Souza, H, Bordin, J O, Bardossy, L, Blajchman, M A

    “…The present measures adopted to prevent transfusion-associated Chagas' disease include screening of blood donors, and/or the inactivation of T. cruzi in…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion : the importance of the timing of the leukodepletion by BORDIN, J. O, BARDOSSY, L, BLAJCHMAN, M. A

    Published in Blood (01-07-1994)
    “…We had reported previously (Blood 81:1880, 1993) that allogeneic blood transfusions (ABT) administered before the infusion of tumor cells in both inbred and…”
    Get full text
    Journal Article
  11. 11

    Allogeneic Blood Transfusion-Induced Enhancement of Tumor Growth: Two Animal Models Showing Amelioration by Leukodepletion and Passive Transfer Using Spleen Cells by Blajchman, Morris A., Bardossy, Leslie, Carmen, Raleigh, Sastry, Alison, Singal, Dharam P.

    Published in Blood (01-04-1993)
    “…Allogeneic blood transfusions have been reported to induce immunomodulation in recipients of blood products. While the mechanism(s) of this immunomodulatory…”
    Get full text
    Journal Article
  12. 12

    o-Raffinose cross-linked hemoglobin improves the hemostatic defect associated with anemia and thrombocytopenia in rabbits by Lee, David H., Bardossy, Leslie, Peterson, Nichole, Blajchman, Morris A.

    Published in Blood (15-11-2000)
    “…Several different preparations of cross-linked hemoglobin (CLHb) are being evaluated for their efficacy and safety as red cell substitutes in a variety of…”
    Get full text
    Journal Article
  13. 13

    An Animal Model of Allogeneic Donor Platelet Refractoriness: The Effect of the Time of Leukodepletion by Blajchman, Morris A., Bardossy, Leslie, Carmen, Raleigh A., Goldman, Mindy, Heddle, Nancy M., Singal, Dharam P.

    Published in Blood (01-03-1992)
    “…Approximately 50% of multi-transfused individuals become refractory to random donor platelets. Recent clinical data suggest that those patients receiving…”
    Get full text
    Journal Article
  14. 14

    The procoagulant state of the VX-2 tumor in rabbit lung in vivo--relative accumulation of fibrinogen, prothrombin, plasminogen, antithrombin and heparin cofactor II within the tumor by Hatton, M W, Ross, B, Bardossy, L, Southward, S M, DeReske, M, Richardson, M, Blajchman, M A

    Published in Thrombosis and haemostasis (01-12-1999)
    “…During their growth, many malignant solid tumors elicit a hemostatic response in the host. In this report, the fluxes of various rabbit plasma hemostatic…”
    Get more information
    Journal Article
  15. 15

    Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of the leukodepletion by Bordin, JO, Bardossy, L, Blajchman, MA

    Published in Blood (01-07-1994)
    “…We had reported previously (Blood 81:1880, 1993) that allogeneic blood transfusions (ABT) administered before the infusion of tumor cells in both inbred and…”
    Get full text
    Journal Article
  16. 16

    Assessment of the Hemostatic Effectiveness of Human Platelets Treated With Aminomethyltrimethyl Psoralen and UV A Light Using a Rabbit Ear Bleeding Time Technique by Wagner, Stephen J., Bardossy, Leslie, Moroff, Gary, Dodd, Roger Y., Blajchman, Morris A.

    Published in Blood (01-12-1993)
    “…The photochemical aminomethyltrimethyl psoralen (AMT), in conjunction with UV A light (UVA), has been shown to inactivate human immunodeficiency virus-1 and…”
    Get full text
    Journal Article
  17. 17

    Assessment of the hemostatic effectiveness of human platelets treated with aminomethyltrimethyl psoralen and UV A light using a rabbit ear bleeding time technique by Wagner, SJ, Bardossy, L, Moroff, G, Dodd, RY, Blajchman, MA

    Published in Blood (01-12-1993)
    “…The photochemical aminomethyltrimethyl psoralen (AMT), in conjunction with UV A light (UVA), has been shown to inactivate human immunodeficiency virus-1 and…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Allogeneic blood transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells [see comments] by Blajchman, MA, Bardossy, L, Carmen, R, Sastry, A, Singal, DP

    Published in Blood (01-04-1993)
    “…Allogeneic blood transfusions have been reported to induce immunomodulation in recipients of blood products. While the mechanism(s) of this immunomodulatory…”
    Get full text
    Journal Article
  20. 20

    An animal model of allogeneic donor platelet refractoriness: the effect of the time of leukodepletion by Blajchman, MA, Bardossy, L, Carmen, RA, Goldman, M, Heddle, NM, Singal, DP

    Published in Blood (01-03-1992)
    “…Approximately 50% of multi-transfused individuals become refractory to random donor platelets. Recent clinical data suggest that those patients receiving…”
    Get full text
    Journal Article